Navigation Links
Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin
Date:8/28/2008

kaline phosphatase (ALP) ranging from no effect in the lowest dose group to a marked reduction in the higher dose groups. ALP is a severity marker of bony metastatic disease and of prognostic importance.

The study has also further confirmed the safety of Alpharadin and shown its benign side-effect profile. In fact, the higher the dose of Alpharadin that patients received, the fewer adverse events were experienced. This reproduces the safety profile of the earlier BC1-02 Phase II study where the Alpharadin group experienced fewer adverse effects than the placebo comparator group. Importantly for a drug in this clinical setting no significant bone marrow toxicity was observed in patients receiving Alpharadin.

The full results of the BC1-03 study will be submitted for publication in a peer-reviewed journal.

The principal investigator of the study Professor Sten Nilsson at the Karolinska Hospital in Stockholm said: "These results showing the beneficial impact of Alpharadin in terms of pain palliation are important, as improved quality of life, alongside increased survival, are the two key goals of anti-cancer therapy of patients with skeletal metastases."

Commenting on today's further positive news with Alpharadin, Algeta's President and CEO, Dr. Thomas Ramdahl, said: "These results build on the positive Phase II clinical data package that we have already assembled with Alpharadin, the highlight of which was the significant survival benefits that we have already reported in patients with HRPC.

Based on our clinical trials to-date I am very confident that Alpharadin has the potential to become an important new therapy for patients with prostate cancer. This view has been reinforced by the enthusiastic and positive response we have received from key opinion leaders around the world to our unique approach to treating HRPC."

Algeta has recently started enrolling patients for the pivotal Phase III ALSYMPCA (ALpharadin in SYMptomatic
'/>"/>

SOURCE Algeta
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmasset Reports Financial Results for Quarter Ended June 30, 2008
2. Cardium Reports on Second Quarter 2008 Highlights and Financial Results
3. Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling
4. Alexza Reports 2008 Second Quarter Financial Results and Updates Development of Product Candidates
5. Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
6. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
7. CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
8. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
9. Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study
10. Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacells ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
11. Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014  Alexza Pharmaceuticals, Inc. (Nasdaq: ... on its pipeline and new product development efforts. In ... initiate a Phase 2a study of AZ-002 (Staccato ... the management of patients with acute repetitive seizures. ... -based product candidates for development - AZ-008 and ...
(Date:7/31/2014)... -- Decision Resources Group is launching an extension of its ... include ChinaTrack; the new capabilities track the ... providing detailed brand-level share tracking and analytics. ChinaTrack also ... Other key capabilities of the new line extension: ... end-user surveys of healthcare facilities, ChinaTrack data is paired ...
(Date:7/31/2014)... July 31, 2014 For its innovative modular ... , Art,s-Way Scientific has earned a Modular Building ... competition in over 30 categories, MBI,s contest is the ... which include building manufacturers, dealers, and product and service ... example the capability of our team," said Dan ...
Breaking Medicine Technology:Alexza Provides Pipeline Update 2Alexza Provides Pipeline Update 3Alexza Provides Pipeline Update 4Alexza Provides Pipeline Update 5Alexza Provides Pipeline Update 6Decision Resources Group Announces First Medical Device Account Targeting Tool in China 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 3Art's Way Scientific Earns Prestigious Modular Building Institute Award 4
(Date:7/31/2014)... CO (PRWEB) July 31, 2014 LDM ... new eDiscovery pricing model that is simplified and predictable ... any size. As a leading international provider of ... government agencies it has become glaringly apparent that both ... unpredictable ballooning eDiscovery budgets and the complex pricing structure ...
(Date:7/31/2014)... News) -- With the World Health Organization reporting that ... has risen to 729, the U.S. Centers for ... warning for,the region. The "Level 3 travel advisory" ... -- Guinea, Liberia and Sierra Leone -- be avoided. ... in West Africa," CDC Director Dr. Tom Frieden told ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Setting goals for ... on blogs on successful tips to weight loss. Fitness on ... for over 8 years, and has worked with 6000 customers ... “We have had the chance to monitor why customers start ... exercising, how long they stick to their program, whether or ...
(Date:7/31/2014)... The VitalSleep anti snoring device is a mandibular ... open a snorers airway to quiet snoring. , Dawn M. ... relationship with her husband by allowing them to share the same ... snoring began about 15 years ago and I remember nights when ... sleep and had to head downstairs for any relief. As the ...
(Date:7/31/2014)... New York (PRWEB) July 31, 2014 ... grow, as Bernstein Liebhard LLP notes that Johnson ... it plans to voluntarily remove its power morcellators ... a report from Bloomberg.com, the company said it ... benefits associated with the devices remain uncertain.* , ...
Breaking Medicine News(10 mins):Health News:LDM Global Announces Predictable Simple Fixed-Fee Pricing 2Health News:CDC Issues Travel Warning as West Africa Ebola Outbreak Worsens 2Health News:Fitness on the Go's Rewards Program Helps Clients Reach Their Goals 2Health News:New Snoring Mouthpiece Reviews from VitalSleep 2Health News:Uterine Morcellation Controversy Grows, as Bernstein Liebhard LLP Notes Johnson & Johnson Decision to Withdraw Power Morcellators from Market 2Health News:Uterine Morcellation Controversy Grows, as Bernstein Liebhard LLP Notes Johnson & Johnson Decision to Withdraw Power Morcellators from Market 3
... explore the relationship between the size of a brain structure ... been found out that the same region // of the ... the overall personality of the individual. , It ... an area of the brain called the medial orbitofrontal cortex ...
... that the weight gained during the holiday season is never ... ,The weight gain starts from the Thanksgiving weekend and ... of the holiday bulge., ,To stop this bulge a ... more fruits and non-fat yogurt, drink skimmed milk, drink in ...
... Christina Desforges a teenage girl died due to Peanut allergy ... , Desforges is from the city of Saguenay, though ... she could not be cured of the hypersensitivity reaction and ... the death is being investigated and an autopsy has been ...
... grants that were designed to nlure health practioners to distant ... failed for the dental segment in the Scottish area of ... grant per dentist to enable them to move to areas ... It has emerged not that only about five dentists have ...
... outbreak of H5N1 avian influenza has been confirmed in ... bird flu outbreak is the 23rd in China since ... died in Inner Mongolia's Zalantun city last Sunday, the ... 16,567 birds at poultry farms within three,km of the ...
... journal Nutrition and Cancer says that Zyflamend, an herbal extract from ... prostate cancer.// ,It was found that this element caused ... the drug had the ability to inhibit 78 percent of the ... natural process by which a cell dies. Cell death in this ...
Cached Medicine News:Health News:Fear Factor Found To Be Crucial In Shaping An Individual’s Personalit 2
Microsurgical curved forceps made of titanium has curved shafts with smooth working surface. TCI working parts 6 mm from tips with round handle, diam. 6 mm, overall length 116 mm....
Microsurgical straight forceps made of titanium has straight shafts with smooth working surface. TCI working parts 6 mm from tips with round handle, diam. 6 mm, overall length 116 mm....
Girard angled tying forceps made of titanium has angled 45 shafts with 4 mm tying platforms, width of shafts 0,25 mm, TCI platforms, round handle, diam. 6 mm, overall length 102 mm....
Angled tying forceps made of titanium has angled shafts with 6 mm V-grove tying platforms, width of shafts 0,5 mm, TCI platforms, flat handle, width 10 mm, overall length 102 mm....
Medicine Products: